Hattori M, Honma N, Nagai S, Narui K, et al. Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines. Breast Cancer 2024 Mar 4. doi: 10.1007/s12282-024-01550.
PMID: 38433181